scholarly article | Q13442814 |
P356 | DOI | 10.1021/ACSAMI.7B06464 |
P698 | PubMed publication ID | 28762264 |
P50 | author | Bi-Feng Liu | Q89301089 |
Peng Chen | Q89773153 | ||
P2093 | author name string | Wei Li | |
Jie Wang | |||
Wei Du | |||
Xiaojun Feng | |||
Leicheng Zhang | |||
Lin Ban | |||
P4510 | describes a project that uses | microfluidics | Q138845 |
P433 | issue | 33 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microfluidics | Q138845 |
drug delivery | Q1392806 | ||
microfluidic device | Q105460056 | ||
P304 | page(s) | 27441-27452 | |
P577 | publication date | 2017-08-01 | |
P1433 | published in | ACS Applied Materials and Interfaces | Q2819060 |
P1476 | title | Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells | |
P478 | volume | 9 |
Q92853277 | Application of Microfluidic Chips in Separation and Analysis of Extracellular Vesicles in Liquid Biopsy for Cancer |
Q99609581 | Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer |
Q64271846 | Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy |
Q91962415 | Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine |
Q92441044 | Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine |
Q64898428 | Enhancement of optical force acting on vesicles via the binding of gold nanoparticles. |
Q92222186 | Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy |
Q90544072 | Isolation and Profiling of Circulating Tumor-Associated Exosomes Using Extracellular Vesicular Lipid-Protein Binding Affinity Based Microfluidic Device |
Q88747170 | Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics |
Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
Q47589106 | The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis |
Search more.